Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid Users
This study has been completed.
Study NCT01596673   Information provided by Teva Pharmaceutical Industries

First Received on March 30, 2012.   Last Updated on November 20, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Drug Abuse
Additional conditions recognized in this trial
Substance-Related Disorders
More general conditions related to this trial
Mental Disorders
Interventions listed in this trial
Placebo
Additional drug interventions recognized in this trial
Analgesics, Opioid
Hydrocodone
More general drug interventions related to this trial
Analgesics
Antitussive Agents
Central Nervous System Agents
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Cephalon


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services